International journal of clinical and experimental pathology · 2014
Homozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with myeloid neoplasms.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tang Guilin, Lu Xinyan, Wang Sa A, Roney Erin K, Zhang Liping, Hu Shimin, Lu Gary, Medeiros L Jeffrey, Patel Ankita
Аннотация
Rearrangements of the MLL gene located at chromosome 11q23 are common chromosomal abnormalities associated with acute leukemias. In vast majority of cases with MLL gene rearrangements, only one chromosome 11 or a single MLL allele got involved. We report two very unusual cases of myeloid neoplasms with homozygous inv(11)(q21q23) and biallelic MLL rearrangement. Both patients, a 12-year old boy and a 29-year old woman, presented initially with T lymphoblastic leukemia/lymphoma (T-ALL), achieved complete remission with intensive chemotherapy, then recurred as acute myeloid leukemia in one patient and therapy-related myelodysplastic syndromes in the other patient, 24 and 15 months after initial T-ALL diagnosis, respectively. In both cases, biallelic MLL gene rearrangements were confirmed by fluorescence in situ hybridization. Mastermind like 2 gene was identified as MLL partner gene in one case. To our knowledge, homozygous inv(11)(q21q23) with two MLL genes rearrangement are extremely rare; it is likely a result of acquired uniparental disomy.
Предметные рубрики MeSH
AdultChildChromosome InversionChromosomes, Human, Pair 11FemaleGene RearrangementHistone-Lysine N-MethyltransferaseHumansIn Situ Hybridization, FluorescenceLeukemia, MyeloidMaleMyelodysplastic SyndromesMyeloid-Lymphoid Leukemia ProteinNeoplasm Recurrence, LocalNeoplasms, Second PrimaryPrecursor Cell Lymphoblastic Leukemia-Lymphoma